Protalix Biotherapeutics
PLXProtalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at Protalix Biotherapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 12/19/2025 | Buy | Bashan, Dror | PRESIDENT AND CEO | $1.8 | $101,360 |
| 11/18/2025 | Sell | Bar-Shalev, Amos | Director | $1.9 | $314 |
| 6/10/2025 | Buy | Schwartz, Aharon | Director | $1.6 | $205,884 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)